Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices 5503 

Drug Schedule 

Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II 

Morphine (9300) .......................................................................................................................................................................................... II 

Thebaine (9333) .......................................................................................................................................................................................... II 

Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II 

Oxymorphone (9652) ................................................................................................................................................................................... II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

Racemethorphan (9732) .............................................................................................................................................................................. II 

Alfentanil (9737) .......................................................................................................................................................................................... II 

Remifentanil (9739) ..................................................................................................................................................................................... II 

Sufentanil (9740) ......................................................................................................................................................................................... II 

Carfentanil (9743) ........................................................................................................................................................................................ II 

Tapentadol (9780) ....................................................................................................................................................................................... II 

Fentanyl (9801) ........................................................................................................................................................................................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Cerilliant Corporation to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Cerilliant Corporation to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems; verification of the 

company’s compliance with state and 

local laws; and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: January 15, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–01533 Filed 1–24–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances, Notice of Registration; 

Morton Grove Pharmaceuticals 

By Notice dated September 25, 2012, 

and published in the Federal Register 

on October 2, 2012, 77 FR 60144, 

Morton Grove Pharmaceuticals, 6451 

Main Street, Morton Grove, Illinois 

60053–2633, made application by letter 

to the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of Gamma Hydroxybutyric 

Acid (2010), a basic class of controlled 

substance listed in schedule I. 

The company plans to manufacture 

the listed controlled substance for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a), and 

determined that the registration of 

Morton Grove Pharmaceuticals to 

manufacture the listed basic class of 

controlled substance is consistent with 

the public interest at this time. DEA has 

investigated Morton Grove 

Pharmaceuticals to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems; verification of the 

company’s compliance with state and 

local laws; and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic class of 

controlled substance listed. 

Dated: January 14, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–01592 Filed 1–24–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Statement 

of Expenditures and Financial 

Adjustment of Federal Funds for 

Unemployment Compensation for 

Federal Employees and ExServicemembers 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(DOL) is submitting the Employment 

and Training Administration (ETA) 

sponsored information collection 

request (ICR) titled, ‘‘Statement of 

Expenditures and Financial Adjustment 

of Federal Funds for Unemployment 

Compensation for Federal Employees 

and Ex-Servicemembers,’’ (Reporting 

Form ETA–191) to the Office of 

Management and Budget (OMB) for 

review and approval for continued use 

in accordance with the Paperwork 

Reduction Act (PRA) of 1995 (44 U.S.C. 

3501 et seq.). 

DATES: Submit comments on or before 

February 25, 2013. 

ADDRESSES: A copy of this ICR with 

applicable supporting documentation; 

including a description of the likely 

respondents, proposed frequency of 

response, and estimated total burden 

may be obtained from the RegInfo.gov 

Web site, http://www.reginfo.gov/ 

public/do/PRAMain, on the day 

following publication of this notice or 

by contacting Michel Smyth by 

telephone at 202–693–4129 (this is not 

a toll-free number) or sending an email 

to DOL_PRA_PUBLIC@dol.gov. 

Submit comments about this request 

to the Office of Information and 

Regulatory Affairs, Attn: OMB Desk 

Officer for DOL–ETA, Office of 

Management and Budget, Room 10235, 

725 17th Street NW., Washington, DC 

20503, Fax: 202–395–6881 (this is not a 

mstockstill on DSK4VPTVN1PROD with 

5504 Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices 

toll-free number), email: 

OIRA_submission@omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: 

Contact Michel Smyth by telephone at 

202–693–4129 (this is not a toll-free 

number) or by email at 

DOL_PRA_PUBLIC@dol.gov. 

Authority: 44 U.S.C. 3507(a)(1)(D). 

SUPPLEMENTARY INFORMATION: Federal 

civilian and military agencies must 

reimburse the Federal Employees 

Compensation Account for the amount 

expended for benefits to former Federal 

civilian employees and exservicemembers. The ETA–191 report 

informs the ETA of the amount to bill 

such agencies. 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless it is 

approved by the OMB under the PRA 

and displays a currently valid OMB 

Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid Control Number. See 5 

CFR 1320.5(a) and 1320.6. The DOL 

obtains OMB approval for this 

information collection under Control 

Number 1205–0162. The current 

approval is scheduled to expire on 

January 31, 2013; however, it should be 

noted that existing information 

collection requirements submitted to the 

OMB receive a month-to-month 

extension while they undergo review. 

For additional information, see the 

related notice published in the Federal 

Register on September 18, 2012. 

Interested parties are encouraged to 

send comments to the OMB, Office of 

Information and Regulatory Affairs at 

the address shown in the ADDRESSES

section within 30 days of publication of 

this notice in the Federal Register. In 

order to help ensure appropriate 

consideration, comments should 

mention OMB Control Number 1205– 

0162. The OMB is particularly 

interested in comments that: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Agency: DOL–ETA. 

Title of Collection: Statement of 

Expenditures and Financial Adjustment 

of Federal Funds for Unemployment 

Compensation for Federal Employees 

and Ex-Servicemembers. 

OMB Control Number: 1205–0162. 

Affected Public: State, Local, and 

Tribal Governments. 

Total Estimated Number of 

Respondents: 53. 

Total Estimated Number of 

Responses: 212. 

Total Estimated Annual Burden 

Hours: 1,272. 

Total Estimated Annual Other Costs 

Burden: $0. 

Dated: January 17, 2013. 

Michel Smyth, 

Departmental Clearance Officer. 

[FR Doc. 2013–01513 Filed 1–24–13; 8:45 am] 

BILLING CODE 4510–FW–P 

OFFICE OF THE DIRECTOR OF 

NATIONAL INTELLIGENCE 

Agency Information Collection 

Activities: Extension of Information 

Collection; Comment Request 

AGENCY: Office of the Director of 

National Intelligence (ODNI). 

ACTION: Notice and comment. 

SUMMARY: In December 2011, the ODNI 

accepted responsibility from the 

Information Security Oversight Office 

(ISOO) for the maintenance of Standard 

Form 312: Classified Information 

Nondisclosure Agreement; Standard 

Form 713: Consent For Access to 

Records; and Standard Form 714: 

Financial Disclosure Report, which are 

directly related to responsibilities 

assigned to the Director of National 

Intelligence (DNI) as Security Executive 

Agent. Accordingly, ODNI is giving 

public notice regarding extension of the 

currently approved information 

collection, Financial Disclosure Report, 

Standard Form 714, which candidates 

for national security clearance must 

submit as a condition of access to 

specifically designated classified 

information along with a favorably 

adjudicated personnel security 

background investigation or 

reinvestigation that results in the 

granting or updating of a security 

clearance. ODNI is proposing no 

changes to the Standard Form 714 and 

its instructions at this time. The public 

is invited to comment on the 

information collection pursuant to the 

Paperwork Reduction Act of 1995. 

DATES: Written comments must be 

received on or before March 26, 2013 to 

be assured of consideration. 

ADDRESSES: Comments should be sent 

to: dni-foia@dni.gov. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection and 

supporting statement should be directed 

to Mr. John Hackett, Office of the Chief 

Information Officer, Information and 

Data Management Group, Office of the 

Director of National Intelligence, 

Washington, DC 20511. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Paperwork Reduction Act of 1995 

(Pub. L. 104–13), ODNI invites the 

general public and other Federal 

agencies to comment on Standard Form 

714. The comments and suggestions 

should address one or more of the 

following points: (a) Whether the 

proposed information collection 

reflected in the Standard Form 714 

meets the intent of § 1.3 (‘‘Financial 

Disclosure’’) of Executive Order 12968 

(‘‘Access to Classified Information’’); (b) 

the accuracy of the estimated burden of 

the proposed information collection for 

Standard Form 714; (c) ways to enhance 

the quality, utility, and clarity of the 

information to be collected in the 

Standard Form 714; (d) ways, including 

the use of information technology, to 

minimize the burden of the collection of 

information on all respondents to the 

Standard Form 714; and (e) whether 

small businesses are affected by this 

collection. The comments that are 

submitted will be summarized and 

included in the ODNI request for Office 

of Management and Budget (OMB) 

approval. All comments will become a 

matter of public record. 

Abstract: The National Security Act of 

1947, as amended by the Intelligence 

Reform and Terrorism Prevention Act of 

2004, and Executive Order 13467, 

‘‘Reforming Processes Related to 

Suitability for Government 

Employment, Fitness for Contractor 

Employees, and Eligibility for Access to 

Classified National Security 

Information,’’ authorizes the DNI as the 

Security Executive Agent to develop 

standard forms that promote uniformity 

and consistency in the implementation 

mstockstill on DSK4VPTVN1PROD with